
---
title: '药明康德：增发境外上市外资股（H股）获得证监会批复'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=6872'
author: 证券时报网
comments: false
date: Mon, 22 Aug 2022 16:55:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=6872'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" style="color: #2f67d1;text-decoration: none;" code="603259" target="_blank">药明康德</a>(603259)8月22日晚间公告，近日收到中国证监会出具的《关于核准无锡<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" style="color: #2f67d1;text-decoration: none;" code="603259" target="_blank">药明康德</a>新药开发股份有限公司发行境外上市外资股的批复》，核准公司发行不超过7843.43万股境外上市外资股，每股面值1元。</p>

                  
</div>
            